Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 446-451

  Recio Mayoral, Alejandro ^a   Banerjee, Debasish ^a   Streather, Chris ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Carotid intima media thickness; Chronic kidney disease; Endothelial function; Flow mediated dilation; High sensitivity C reactive protein; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79957984039     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.017     Document Type: Article

References (23)

1. Banerjee D., Contreras G., Jaraba I., et al. Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population. Int Urol Nephrol 2009, 41:443-451.
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Foley R.N., Murray A.M., Li S., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005, 16:489-495.
4. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004, 351:1285-1295.
5. Ojo A.O., Hanson J.A., Wolfe R.A., Leichtman A.B., Agodoa L.Y., Port F.K. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000, 57:307-313.
6. Herzog C.A., Ma J.Z., Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998, 339:799-805.
7. Herzog C.A., Ma J.Z., Collins A.J. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000, 36:145-152.
8. Schiffrin E.L., Lipman M.L., Mann J.F. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116:85-97.
9. Menon V., Greene T., Wang X., et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005, 68:766-772.
10. Cross J.M., Donald A., Vallance P.J., Deanfield J.E., Woolfson R.G., MacAllister R.J. Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001, 16:1823-1829.
11. Oflaz H., Pusuroglu H., Genchallac H., et al. Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant 2003, 17:528-533.
12. Kocak H., Ceken K., Yavuz A., et al. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol Dial Transplant 2006, 21:203-207.
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
14. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
15. Wendelhag I., Gustavsson T., Suurkula M., Berglund G., Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991, 11:565-577.
16. Wikstrand J. Methodological considerations of ultrasound measurement of carotid artery intima-media thickness and lumen diameter. Clin Physiol Funct Imaging 2007, 27:341-345.
17. Masci P.G., Laclaustra M., Lara J.G., Kaski J.C. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005, 95:1478-1480.
18. Newey V.R., Nassiri D.K. Online artery diameter measurement in ultrasound images using artificial neural networks. Ultrasound Med Biol 2002, 28:209-216.
19. Prasad N., Kumar S., Singh A., et al. Carotid intimal thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2009, 29(Suppl. 2):S96-S101.
20. Nanayakkara P.W., van G.C., ter Wee P.M., et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 2007, 167:1262-1270.
21. Wilson A.C., Urbina E., Witt S.A., Glascock B.J., Kimball T.R., Mitsnefes M. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr Nephrol 2008, 23:1297-1302.
22. Yilmaz M.I., Saglam M., Sonmez A., et al. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan. Blood Purif 2007, 25:327-335.
23. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009, 78:539-552.